(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Electronics
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > In Vitro Diagnostics >  Cancer
 
 Cancer Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  1  2  3  4  5  6  7  8  9  10  Next »
2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

Summary

This comprehensive five-country report contains 820 pages, 320 tables, and presents analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers....


 

$19700.00
       
Cancer Diagnostics Market: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Summary

This comprehensive five-country report contains 820 pages, 320 tables, and presents analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers....


 

$19700.00
       
2017 Asia-Pacific Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

This new 17-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....


 

$14500.00
       
Cancer Diagnostic Testing: Granular Analysis of the European Market Supplier Shares and Forecasts for Current and Emerging Tumor Markers France, Germany, Italy, Spain, UK

This DataPack contain 320 tables from Venture Planning Group new 5-country study, “Competing in the European Cancer Diagnostics Market,” including supplier shares, as well as test volume and sales forecasts for 40 tumor markers. The DataPack will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European cancer diagnostics market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

 

$12800.00
       
2017 North America Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

This new 3-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....


 

$10500.00
       
2017 Middle East Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

This new 11-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....


 

$9850.00
       
Competing in the US Cancer Diagnostics Market

Highlights

This new 620-page study of the US cancer diagnostics market from Venture Planning Group provides:

  • Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Mortality statistics and scientific views on the etiology of major types of cancer, e....

 

$9800.00
       
US Cancer Diagnostics Market Outlook: Innovations, Trends and Opportunities for Suppliers

This report presents a comprehensive analysis of the US cancer diagnostics market, including: 
  • Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Mortality statistics and scientific views on the etiology of major types of cancer, e....

 

$9800.00
       
2014 Opportunities in the US Cancer Diagnostics Market

“2014 Opportunities in the US Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the US cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

 

$9800.00
       
2014 Analysis of the US Cancer Diagnostics Market:
Sales Forecasts, Supplier Shares, Competitive Strategies


“2014 Analysis of the US Cancer Diagnostics Market: Sales Forecasts, Supplier Shares, Competitive Strategies” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the US cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

 

$9800.00
       
US Cancer Diagnostics Market 2014: Sales Forecasts, Supplier Shares, Competitive Strategies

“US Cancer Diagnostics Market 2014: Sales Forecasts, Supplier Shares, Competitive Strategies” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the US cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

 

$9800.00
       
New Frontiers in the US Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape

“New Frontiers in the US Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group’s new study of the major business opportunities emerging in the U.S....

 

$9800.00
       
2015 US Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies

"2015 US Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years.  The report examines trends in the US cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

 

$9800.00
       
2014 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

“2014 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations” is Venture Planning Group’s new study of the major business opportunities emerging in the US cancer diagnostics market during the next five years....


 

$9800.00
       
Future Horizons and Growth Strategies in the US Cancer Diagnostics Market 2014: Supplier Shares and Country Forecasts

This is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the US cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

 

$9800.00
       
2014-2018 US Cancer Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies

“2014-2018 US Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the US cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

 

$9800.00
       
2015 US Cancer Diagnostics Market: Emerging Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Supplier Shares, Country Segment Forecasts, Competitive Strategies

"2015 US Cancer Diagnostics Market” is a new strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years.  The report examines trends in the US cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

 

$9800.00
       
2016 New Frontiers in the US Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape

“2016 New Frontiers in the US Cancer Diagnostics Market” is VPGMarketResearch’s new study of the major business opportunities emerging in the U.S....

 

$9800.00
       
« Previous     1  2  3  4  5  6  7  8  9  10   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X